Skip to main content

Table 6 Patients’ biological profile at day 7 post treatment

From: Efficacy and tolerability of a new formulation of artesunate-mefloquine for the treatment of uncomplicated malaria in adult in Senegal: open randomized trial

  AM AL p value
  Day 7 Day 7  
Mean haemoglobin 11.3 ± 1.8 10.6 ± 1.5 0.11
Anaemia (%) 86 (54.7%) 105 (68.6%) 0.01
Median ALAT 19 19.3 0.93
Median ASAT 24 25 0.53
Patients with ASAT < 40 (%) 143 (91%) 139 (90.8%) 0.94
Patients with ALAT < 40 (%) 146 (92.9%) 145 (94.7%) 0.51
Mean creatinine 7.7 ± 4.7 8.2 ± 7.0 0.50
Patients with normal level of creatinine (%) 149 (94.9%) 150 (98.0%) 0.13
Median bilirubin 1.10 1.08 0.36
Patients with normal level of bilirubin (%) 92 (58.6%) 82 (53.6%) 0.37